Nedosiran: Side Effects, Uses & Monitoring

Facts extracted from current FDA product labeling for Nedosiran. Educational only — not medical advice.

Labeled uses

RIVFLOZA is indicated to lower urinary oxalate levels in children 2 years of age and older and adults with primary hyperoxaluria type 1 (PH1) and relatively preserved kidney function, e.g., eGFR ≥30 mL/min/1.73 m2 [see Clinical Pharmacology (‎12.3 )], Clinical Studies (‎14.1 )].

Source: FDA labeling via NIH DailyMed (set ace9d4bc…). Not affiliated with FDA or NIH.

Medical disclaimer: Always consult a qualified healthcare professional about any medication.

Ratings summarize government-reported measures — they don't capture your personal needs. Visit the facility, ask about staffing and services, and use CMS checklists. This profile is informational only and is not a recommendation.